STOCK TITAN

Insider John Couling to sell Dolby (DLB) shares worth about $432K

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Dolby Laboratories insider John Couling has filed to sell additional common shares under Rule 144. The notice covers 6,667 common shares to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 02/02/2026, with an aggregate market value of 432,588.30. The filing notes 60,884,768 common shares outstanding and lists the NYSE as the trading venue.

The shares to be sold were originally acquired from the issuer as restricted stock and performance shares on various grant dates between 12/15/2020 and 12/15/2023. Over the past three months, Couling previously sold 7,273 common shares on 12/11/2025 for gross proceeds of 500,018.75 and 6,164 common shares on 11/20/2025 for gross proceeds of 407,563.68.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the latest Rule 144 filing for Dolby (DLB) disclose?

The filing shows insider John Couling plans to sell 6,667 Dolby common shares. The planned sale has an aggregate market value of 432,588.30 and will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 02/02/2026 on the NYSE.

How many Dolby (DLB) shares is John Couling planning to sell under this notice?

John Couling plans to sell 6,667 Dolby common shares under this Rule 144 notice. The planned transaction has an aggregate market value of 432,588.30 and is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services on or about 02/02/2026.

What recent Dolby (DLB) stock sales has John Couling already completed?

Over the past three months, John Couling sold 7,273 Dolby common shares on 12/11/2025 and 6,164 shares on 11/20/2025. These transactions generated gross proceeds of 500,018.75 and 407,563.68 respectively, reflecting prior insider selling activity before the newly filed planned sale.

How were the Dolby (DLB) shares being sold by John Couling originally acquired?

The shares in this filing were acquired from Dolby as restricted stock and performance shares. Grants occurred on several dates, including 12/15/2020, 12/16/2020, 12/17/2021, 12/15/2021, and 12/15/2023, with amounts ranging from 12 to 2,207 shares per grant.

How many Dolby (DLB) shares are outstanding according to this filing?

The notice reports 60,884,768 Dolby common shares outstanding. This figure provides context for the scale of John Couling’s planned sale of 6,667 shares and his recent sales of 7,273 and 6,164 shares over the preceding three months.

Through which broker and exchange will the Dolby (DLB) insider sale occur?

The planned sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing identifies the NYSE as the securities exchange for the 6,667 Dolby common shares scheduled for sale on or about 02/02/2026 under Rule 144.
Dolby Laboratories Inc

NYSE:DLB

DLB Rankings

DLB Latest News

DLB Latest SEC Filings

DLB Stock Data

6.13B
59.67M
1.35%
98.06%
1.9%
Specialty Business Services
Patent Owners & Lessors
Link
United States
SAN FRANCISCO